China News
-
Boehringer China sees 32% rise in prescription drugs
China | Company results | By BioSpectrum Bureau | 5 Comment | 26 Apr, 2013
Singapore: Boehringer Ingelheim China's prescription medicine business has outperformed the market with a growth rate of...Read more
-
Herbalife will do direct-selling in China
China | News | By BioSpectrum Bureau | 0 Comment | 23 May, 2012
Singapore: Herbalife received eight licenses by China's Ministry of Commerce to conduct its direct-selling business in H...Read more
-
China Jo-Jo Drugstores collaborates with Wyeth
China | News | By BioSpectrum Bureau | 0 Comment | 29 Apr, 2015
Singapore: Hangzhou Jiuzhou Grand Pharmacy Chain, subsidiary of China Jo-Jo Drugstores, has signed a sales incentive agr...Read more
-
Aetna, Starr International form alliance in Hong Kong
China | News | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
Singapore: Aetna, a global diversified healthcare benefits company, and Starr International Insurance have formed a stra...Read more
-
China: Hepatitis B vaccines not cause of deaths
China | News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2014
Singapore: Concluding an elaborate probe that started late last year, China has now said that the hepatitis B vaccines w...Read more
-
China cracks the whip on big pharma
China | Opinion | By BioSpectrum Bureau | 0 Comment | 02 Jun, 2014
Two separate but equally important developments took place in China this month. One, intensification of investigations i...Read more
-
GSK China's former head assisting in investigations
China | News | By BioSpectrum Bureau | 0 Comment | 17 Oct, 2013
Singapore: British drugmaker GlaxoSmithKline that has been facing bribery allegations in China has now said that its for...Read more
-
Sinovac reports positive results from EV71 trial
China | News | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
Singapore: Sinovac Biotech, a provider of vaccines in China, reported preliminary top-line data from its phase III clin...Read more
-
China Biologic names David Gao as CEO
China | News | By BioSpectrum Bureau | 0 Comment | 14 May, 2012
Singapore: China Biologic Products, one of the leading plasma-based biopharmaceutical companies in China, has appointed ...Read more
-
GlobalData: China pharma to reach $315 bn in 2020
China | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013
Singapore: GlobalData has in its latest report on China's healthcare industry highlighted that the country's pharmaceuti...Read more
-
Shanghai Pharma revenue rises 17.6% to $3.17 bn
China | Company results | By BioSpectrum Bureau | 5 Comment | 30 Apr, 2013
‎Singapore: Shanghai Pharmaceuticals has maintained a steady growth in first quarterly result of 2013 touching ope...Read more
-
China Botanic hires Zhao to gain NYSE compliance
China | News | By BioSpectrum Bureau | 0 Comment | 25 Jan, 2013
Singapore: China Botanic Pharmaceutical has appointed Mr Jack Zhao as a member of the company's board of directors. Mr Z...Read more
-
Sanofi opens insulin pen plant at Beijing
China | News | By BioSpectrum Bureau | 0 Comment | 28 May, 2012
Singapore: Sanofi inaugurated a new assembling and packaging line to produce its flagship pre-filled insulin injection p...Read more
-
DKSH launches Dr Wolff's Alpecin in Hong Kong
China | News | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2013
Singapore: DKSH's Business Unit Healthcare, the leading market expansion services provider for healthcare companies seek...Read more
-
ScinoPharm, TaiGen collaborate for stem cell drug
China | News | By BioSpectrum Bureau | 0 Comment | 09 Jun, 2014
Singapore: Taiwan based ScinoPharm, engaged in development and manufacture of active pharmaceutical ingredients has clos...Read more
-
MNCs bet on China to tide over patent cliff
China | Analysis | By BioSpectrum Bureau | 1 Comment | 16 May, 2012
Even as most emerging economies in Asia Pacific are trying to grab a foothold in the global biopharma space, China has e...Read more
-
Whats up with the BGI-Complete acquisition deal?
China | Analysis | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2013
In perhaps the largest move in the sequencing services industry to date, BGI Shenzhen entered into a definitive merger a...Read more
-
Why did mergers & acquisitions plunge in APAC?
China | Analysis | By BioSpectrum Bureau | 1 Comment | 12 Jun, 2013
The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 bill...Read more
